Extracellular vesicles as a promising platform of precision medicine in liver cancer

Keyang XU, Qibiao Wu, Lingyun Zhao, Romario Nguyen, Fatema Safri, William Yang, Yikun Xu , Yun YE, Hiu Yee Kwan, Qiang Wang, Xiuming Liang, Muhammad J.A. Shiddiky, Majid E. Warkiani, Jacob George*, Liang Qiao*, Jianfeng Bao*

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

Abstract

Extracellular vesicles (EVs) are natural carriers of biological information and play pivotal roles in intercellular communication. EVs are biocompatible, have low immunogenicity, and are capable of traversing biological barriers, making them ideal tools for disease diagnosis and therapy. Despite their promising prospects, the full realization of EVs potential faces several challenges. This article aims to comprehensively review the biological and molecular features of EVs, their applications in liver cancer and possible underlying mechanisms, and the critical challenges affecting the clinical translation of EVs-based therapies in liver cancer.
Original languageEnglish
Article number107800
Number of pages11
JournalPharmacological Research
Volume217
Early online date24 May 2025
DOIs
Publication statusPublished - Jul 2025

User-Defined Keywords

  • Extracellular vesicles (EVs)
  • Liver cancer
  • Organoids
  • Standardization
  • Therapeutic tools

Fingerprint

Dive into the research topics of 'Extracellular vesicles as a promising platform of precision medicine in liver cancer'. Together they form a unique fingerprint.

Cite this